|
|
Alternate Title Natural History and Genetic Study of Patients With Von Hippel-Lindau Syndrome and Pancreatic Lesions
Trial Description Diagnostic procedures such as CT scans and MRI may improve the identification of pancreatic lesions in patients who have von Hippel-Lindau syndrome. Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. This clinical trial is studying how well diagnostic and genetic tests work in finding pancreatic lesions in patients with Von Hippel-Lindau syndrome. Eligibility criteria include the following:
Final eligibility for a clinical trial is determined by the health professionals conducting the trial. Patients will undergo imaging procedures, such as CT scan, MRI, and abdominal ultrasound. They will provide blood and urine samples for laboratory and genetic studies. All patients will be offered genetic counseling. Patients may undergo follow-up imaging procedures every 1-2 years. Some patients may undergo surgery. Important: For more details about this trial, refer to the Health Professional version of the trial summary. If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site. Trial Lead Organizations NCI - Center for Cancer Research
Back to Top |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NCI Home |
Text-Only Version |
Contact Us |
Policies |
Accessibility |
RSS |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |